Literature DB >> 22441719

Stronger association of common variants in TCF7L2 gene with nonobese type 2 diabetes in the Latvian population.

I Kalnina1, K Geldnere, L Tarasova, L Nikitina-Zake, R Peculis, D Fridmanis, V Pirags, J Klovins.   

Abstract

Polymorphisms in the gene coding for transcription factor 7 like 2 (TCF7L2) are recognized as the strongest common genetic risk factors for type 2 diabetes (T2D) across multiple ethnicities. This study was conducted to evaluate an association between TCF7L2 variants and diabetes susceptibility in the population of Latvia. We genotyped 4 single nucleotide polymorphisms (SNP) rs7901695, rs7903146, rs11196205 and rs12255372 in 1 093 controls and 1 043 diabetic subjects. Association with T2D was found for 3 SNPs rs7901695, rs7903146 and rs12255372 in the whole sample (under an additive genetic model, the adjusted odds ratios (OR) were 1.26, 95% CI [1.08-1.48], P=0.003; OR=1.32, 95% CI [1.12-1.55], P=0.001 and OR=1.35, 95% CI [1.15-1.60], P=0.0004 respectively). In addition observed effects on T2D susceptibility for analysed SNPs were higher among subjects with BMI under 30 kg/m². The impact of TCF7L2 variation on T2D risk in Latvian population is compatible with that demonstrated by a range of studies conducted in various ethnic groups. © J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22441719     DOI: 10.1055/s-0032-1306298

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  3 in total

1.  Polymorphism of the Transcription Factor 7-Like 2 Gene (TCF7L2) Interacts with Obesity on Type-2 Diabetes in the PREDIMED Study Emphasizing the Heterogeneity of Genetic Variants in Type-2 Diabetes Risk Prediction: Time for Obesity-Specific Genetic Risk Scores.

Authors:  Dolores Corella; Oscar Coltell; Jose V Sorlí; Ramón Estruch; Laura Quiles; Miguel Ángel Martínez-González; Jordi Salas-Salvadó; Olga Castañer; Fernando Arós; Manuel Ortega-Calvo; Lluís Serra-Majem; Enrique Gómez-Gracia; Olga Portolés; Miquel Fiol; Javier Díez Espino; Josep Basora; Montserrat Fitó; Emilio Ros; José M Ordovás
Journal:  Nutrients       Date:  2016-12-06       Impact factor: 5.717

2.  Targeted deletion of Tcf7l2 in adipocytes promotes adipocyte hypertrophy and impaired glucose metabolism.

Authors:  Gisela Geoghegan; Judith Simcox; Marcus M Seldin; Timothy J Parnell; Chris Stubben; Steven Just; Lori Begaye; Aldons J Lusis; Claudio J Villanueva
Journal:  Mol Metab       Date:  2019-03-14       Impact factor: 7.422

Review 3.  Association of rs12255372 in the TCF7L2 gene with type 2 diabetes mellitus: a meta-analysis.

Authors:  Jinjin Wang; Jianfeng Zhang; Linlin Li; Yan Wang; Qian Wang; Yujia Zhai; Haifei You; Dongsheng Hu
Journal:  Braz J Med Biol Res       Date:  2013-04-12       Impact factor: 2.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.